Literature DB >> 12856117

Tubular proteinuria and enzymuria following open heart surgery.

John Blaikley1, Peter Sutton, Mary Walter, Martha Lapsley, Anthony Norden, Wilf Pugsley, Robert Unwin.   

Abstract

OBJECTIVE: We investigated the effect of cardiac surgery on a marker of tubular damage, an enzyme called neutral endopeptidase (NEP), and on a marker of tubular function, retinol binding protein (RBP). Markers of tubular damage or function are useful in the early detection of acute renal failure and help identify the risk factors for this disease. We also examined if colloid interfered with NEP measurement.
DESIGN: A controlled prospective cohort study.
SETTING: A teaching cardio-thoracic unit in London, England. PATIENTS AND PARTICIPANTS: Thirty-four patients underwent cardiac surgery. Eight patients waiting for cardiac surgery acted as controls.
INTERVENTIONS: Twenty-five patients had coronary artery bypass graft, four patients had valve replacements, one patient had a coronary artery bypass graft with a valve replacement and one patient had a left ventricular aneurysm repair. MEASUREMENTS AND
RESULTS: Neutral endopeptidase was measured in all the patients and controls. In separate subgroups RBP ( n=5) and Gelofusine use ( n=12) were recorded. Urine samples were collected pre-operatively, 3 h, 1 and 4 days post-operatively. NEP rose significantly ( p<0.05) after cardiac surgery compared with the control population. RBP also rose significantly ( p<0.05) after cardiac surgery. NEP correlated with RBP 3 h post-operatively ( p<0.05, r(2)=0.97). There was no correlation between the amount of Gelofusine given and NEP excretion.
CONCLUSION: Excretion of NEP and RBP were both increased after cardiac surgery. Colloid did not affect the excretion of NEP, although in other studies it has affected the excretion of RBP. This may make NEP excretion a better index of acute and impending renal damage following cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856117     DOI: 10.1007/s00134-003-1876-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

1.  Sensitive assays for urinary retinol-binding protein and beta-2-glycoprotein-1 based on commercially available standards.

Authors:  M Lapsley; K Akers; A G Norden
Journal:  Ann Clin Biochem       Date:  1998-01       Impact factor: 2.057

2.  The effects of arginine, dextran and Haemaccel infusions on urinary albumin, beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase.

Authors:  D S O'Reilly; E S Parry; J T Whicher
Journal:  Clin Chim Acta       Date:  1986-03-28       Impact factor: 3.786

3.  Independent association between acute renal failure and mortality following cardiac surgery.

Authors:  G M Chertow; E M Levy; K E Hammermeister; F Grover; J Daley
Journal:  Am J Med       Date:  1998-04       Impact factor: 4.965

4.  The effect of a synthetic polypeptide on the renal handling of protein in man.

Authors:  R Beetham; A Dawnay; W Cattell
Journal:  Clin Sci (Lond)       Date:  1987-02       Impact factor: 6.124

5.  In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.

Authors:  M G Spillantini; P Geppetti; M Fanciullacci; S Michelacci; J M Lecomte; F Sicuteri
Journal:  Eur J Pharmacol       Date:  1986-06-05       Impact factor: 4.432

6.  Proximal tubular injury in Chinese herbs nephropathy: monitoring by neutral endopeptidase enzymuria.

Authors:  J L Nortier; M M Deschodt-Lanckman; S Simon; N O Thielemans; E G de Prez; M F Depierreux; C L Tielemans; C Richard; R R Lauwerys; A M Bernard; J L Vanherweghem
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

Review 7.  Assessment of renal function: selected developments.

Authors:  F V Flynn
Journal:  Clin Biochem       Date:  1990-02       Impact factor: 3.281

8.  Pathological release of urinary endopeptidase 24.11 early after renal transplantation.

Authors:  J Nortier; D Abramowicz; P Kinnaert; M Deschodt-Lanckman; J L Vanherweghem
Journal:  Enzyme       Date:  1992
  8 in total
  9 in total

1.  MCP-1 gene activation marks acute kidney injury.

Authors:  Raj Munshi; Ali Johnson; Edward D Siew; T Alp Ikizler; Lorraine B Ware; Mark M Wurfel; Jonathan Himmelfarb; Richard A Zager
Journal:  J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 10.121

2.  Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why.

Authors:  Kai Wen Aaron Tang; Qi Chun Toh; Boon Wee Teo
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

3.  Renal cortical albumin gene induction and urinary albumin excretion in response to acute kidney injury.

Authors:  Lorraine B Ware; Ali C M Johnson; Richard A Zager
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-08

4.  Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate.

Authors:  Sushrut S Waikar; Venkata S Sabbisetti; Joseph V Bonventre
Journal:  Kidney Int       Date:  2010-06-16       Impact factor: 10.612

Review 5.  Biomarkers of acute kidney injury.

Authors:  Charles L Edelstein
Journal:  Adv Chronic Kidney Dis       Date:  2008-07       Impact factor: 3.620

6.  Renal dysfunction after off-pump coronary artery bypass surgery- risk factors and preventive strategies.

Authors:  Gaurab Maitra; Ahsan Ahmed; Amitava Rudra; Ravi Wankhede; Saikat Sengupta; Tanmoy Das
Journal:  Indian J Anaesth       Date:  2009-08

7.  Expression of neutral endopeptidase activity during clinical and experimental acute lung injury.

Authors:  Soshi Hashimoto; Fumimasa Amaya; Kentaro Oh-Hashi; Kazutoshi Kiuchi; Satoru Hashimoto
Journal:  Respir Res       Date:  2010-11-29

8.  DDRGK1 in urine indicative of tubular cell injury in intensive care patients with serious infections.

Authors:  Dashurie Neziri; Sahra Pajenda; Rebecca Amuge; Aysegul Ilhan; Marlene Wewalka; Gregor Hörmann; Christian Zauner; Ludwig Wagner
Journal:  J Nephropathol       Date:  2016-03-31

9.  Urinary neprilysin in the critically ill patient.

Authors:  Sahra Pajenda; Karl Mechtler; Ludwig Wagner
Journal:  BMC Nephrol       Date:  2017-05-25       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.